#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13972	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2105	656.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	830	C,G	804,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26908	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3742	715.0	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	798	C,T	784,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26908	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3742	715.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1672	1672	A	883	A,G,C	861,4,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26908	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3742	715.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	857	C,T	830,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26908	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3742	715.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	825	A	814	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26908	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3742	715.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	807	C,T	776,7	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	V36A	NONSYN	106	108	GTG	407	409	GCG	179;174;174	G,A;C;G	175,1;171;171	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	449	451	CGG	177;176;177	C;G;G	170;168;164	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	S68L	NONSYN	202	204	TCG	503	505	TTG	180;178;179	T,G;T,C;G	160,1;173,3;174	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	A90V	NONSYN	268	270	GCG	569	571	GTT	153;152;151	G;T,C;T,G	146;132,5;141,5	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	I105V	NONSYN	313	315	ATT	614	616	GTT	156;155;154	G;T,G;T	151;141,1;150	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	N125T	NONSYN	373	375	AAT	674	676	ACC	168;169;167	A;C;C	155;163;162	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	R135C	NONSYN	403	405	CGT	704	706	TGT	182;182;182	T,C;G;T,C	158,5;176;159,5	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	K151E	NONSYN	451	453	AAA	752	754	GAA	160;164;163	G,A;A;A,G	158,1;159;159,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	755	757	AAC	162;162;162	A;A,C;C	159;157,1;159	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	A172T	NONSYN	514	516	GCG	815	817	ACA	150;150;152	A;C;A	147;149;150	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	A175E	NONSYN	523	525	GCG	824	826	GAA	157;159;158	G;A;A	153;155;153	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	E176T	NONSYN	526	528	GAA	827	829	ACC	157;157;159	A;C;C	151;151;156	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	I178V	NONSYN	532	534	ATC	833	835	GTC	160;159;162	G;T;C	155;153;156	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	I188T	NONSYN	562	564	ATA	863	865	ACG	162;164;164	A;C;G	154;157;156	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	P200N	NONSYN	598	600	CCC	899	901	AAC	146;148;148	A;A;C	144;141;147	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	F220L	NONSYN	658	660	TTT	959	961	TTG	160;163;164	T;T;GCC,GC	151;156;156,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1016	1018	ACC	141;141;142	A,G,C;C;C,G	134,1,1;134;136,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1019	1021	GAC	143;141;142	G;A;C	136;133;135	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1028	1030	GCG	139;139;138	G;C,T;G	133;114,1;131	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1064	1066	GCT	107;108;108	G,T;C;T,C	99,4;103;94,4	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1529	106.4	1	SNP	p	R230S	1	.	.	688	690	AGC	989	991	AGC	170;172;172	A;G;C	166;168;169	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5348	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3403	156.1	1	SNP	p	S91F	0	.	.	271	273	TCC	570	572	TCC	177;175;179	T;C;C	174;172;176	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5348	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3403	156.1	1	SNP	p	D95G	0	.	.	283	285	GAC	582	584	GAC	180;181;180	G;A;C	180;173;176	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5348	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3403	156.1	1	SNP	p	D95N	0	.	.	283	285	GAC	582	584	GAC	180;181;180	G;A;C	180;173;176	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1596	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1356	116.9	1	SNP	p	G45D	1	.	.	133	135	GAC	487	489	GAC	178;177;177	G;A,G;C	173;166,4;171	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	798	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	945	84.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5030	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2989	167.1	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	195;195;200	G;A,G;C	190;187,1;191	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5030	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2989	167.1	1	SNP	p	S87W	0	.	.	259	261	AGT	553	555	AGT	200;199;203	A;G;T	193;192;190	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5030	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2989	167.1	1	SNP	p	S87I	0	.	.	259	261	AGT	553	555	AGT	200;199;203	A;G;T	193;192;190	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5030	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2989	167.1	1	SNP	p	S87R	0	.	.	259	261	AGT	553	555	AGT	200;199;203	A;G;T	193;192;190	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5030	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2989	167.1	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	200;200;199	T;C;C	192;193;190	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3884	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2624	147.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	200;199;199	G;G;C,A	193;191;190,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1242	1244	GCC	189;190;191	G;C;C	179;183;181	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1245	1247	ATG	189;188;188	A;T;G	181;179;177	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1257	1259	ACC	185;186;187	A,T;C;C	171,1;176;177	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1257	1259	ACC	185;186;187	A,T;C;C	171,1;176;177	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1758	1760	ACC	197;198;203	A;C;C	185;191;197	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1812	1814	GCG	219;219;218	G;C;G	217;216;216	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1812	1814	GCG	219;219;218	G;C;G	217;216;216	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1935	1937	GGT	165;163;161	G;G;T,C	161;157;153,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1944	1946	AGC	158;156;151	A,G;G;C	151,2;152;146	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3800	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2423	155.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1962	1964	CCG	115;118;110	C,G,T;C;G,C	102,1,1;107;89,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5574	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3071	180.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1608	1610	CTG	180;180;181	C;T,C;G	172;167,1;168	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2322	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1817	126.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	148	C	141	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	271	273	AAT	21;21;21	A;A;T	21;20;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	274	276	AAT	21;21;21	A;A;T	21;21;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	298	300	GCA	23;22;22	G;C;A	23;22;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	321	323	GTA	21;19;18	G;T;A	21;19;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	S236N	NONSYN	706	708	AGC	327	329	AAC	18;17;17	A;A;C	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	N237M	NONSYN	709	711	AAC	330	332	ATG	17;17;17	A;T;G	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	288	porB1a	984	318	90.37	porB1a.l15.c30.ctg.2	567	24.1	0	.	p	.	0	D238fs	FSHIFT	712	712	G	333	333	G	17	G	17	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1533	183.5	0	.	p	.	0	E41K	NONSYN	121	123	GAA	369	371	AAA	222;223;224	A,G;A;A	214,2;216;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1533	183.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	879	879	T	223	T	214	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1533	183.5	1	SNP	p	G120K	0	.	.	358	360	GGT	606	608	GGT	248;247;247	G,A;G,A;T,G	238,4;240,3;229,3	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1533	183.5	1	SNP	p	A121N	0	.	.	361	363	GCC	609	611	GCC	249;249;250	G,A;C,A;C	239,3;241,3;243	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1533	183.5	1	SNP	p	A121D	0	.	.	361	363	GCC	609	611	GCC	249;249;250	G,A;C,A;C	239,3;241,3;243	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10044	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4861	204.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1986	1988	CAT	205;206;208	C,A;A;T	199,2;202;203	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1132	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1089	103.0	1	SNP	p	V57M	1	.	.	169	171	ATG	521	523	ATG	218;220;219	A,G;T;G	215,1;216;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
